These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 25893131)
1. A Pharmacokinetic Study of Antimalarial 3,5-Diaryl-2-aminopyridine Derivatives. Dambuza N; Smith P; Evans A; Taylor D; Chibale K; Wiesner L Malar Res Treat; 2015; 2015():405962. PubMed ID: 25893131 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and pharmacokinetic evaluation of a novel anti-malarial compound (NP046) in a mouse model. Abay ET; van der Westuizen JH; Swart KJ; Gibhard L; Lawrence N; Dambuza N; Wilhelm A; Pravin K; Wiesner L Malar J; 2015 Jan; 14():8. PubMed ID: 25563929 [TBL] [Abstract][Full Text] [Related]
3. Antiplasmodial activity, in vivo pharmacokinetics and anti-malarial efficacy evaluation of hydroxypyridinone hybrids in a mouse model. Dambuza NS; Smith P; Evans A; Norman J; Taylor D; Andayi A; Egan T; Chibale K; Wiesner L Malar J; 2015 Dec; 14():505. PubMed ID: 26671222 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic evaluation of Chalcone derivatives with antimalarial activity in New Zealand White Rabbits. Sinha S; Prakash A; Medhi B; Sehgal A; Batovska DI; Sehgal R BMC Res Notes; 2021 Jul; 14(1):264. PubMed ID: 34238361 [TBL] [Abstract][Full Text] [Related]
5. Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial. Gaur AH; McCarthy JS; Panetta JC; Dallas RH; Woodford J; Tang L; Smith AM; Stewart TB; Branum KC; Freeman BB; Patel ND; John E; Chalon S; Ost S; Heine RN; Richardson JL; Christensen R; Flynn PM; Van Gessel Y; Mitasev B; Möhrle JJ; Gusovsky F; Bebrevska L; Guy RK Lancet Infect Dis; 2020 Aug; 20(8):964-975. PubMed ID: 32275867 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship studies of orally active antimalarial 3,5-substituted 2-aminopyridines. González Cabrera D; Douelle F; Younis Y; Feng TS; Le Manach C; Nchinda AT; Street LJ; Scheurer C; Kamber J; White KL; Montagnat OD; Ryan E; Katneni K; Zabiulla KM; Joseph JT; Bashyam S; Waterson D; Witty MJ; Charman SA; Wittlin S; Chibale K J Med Chem; 2012 Dec; 55(24):11022-30. PubMed ID: 23189922 [TBL] [Abstract][Full Text] [Related]
7. 3,5-Diaryl-2-aminopyridines as a novel class of orally active antimalarials demonstrating single dose cure in mice and clinical candidate potential. Younis Y; Douelle F; Feng TS; González Cabrera D; Le Manach C; Nchinda AT; Duffy S; White KL; Shackleford DM; Morizzi J; Mannila J; Katneni K; Bhamidipati R; Zabiulla KM; Joseph JT; Bashyam S; Waterson D; Witty MJ; Hardick D; Wittlin S; Avery V; Charman SA; Chibale K J Med Chem; 2012 Apr; 55(7):3479-87. PubMed ID: 22390538 [TBL] [Abstract][Full Text] [Related]
8. In Vitro and In Vivo Pharmacokinetics of Aminoalkylated Diarylpropanes NP085 and NP102. Gibhard L; Pravin K; Abay E; Wilhelm A; Swart K; Lawrence N; Khoury R; van der Westhuizen J; Smith P; Wiesner L Antimicrob Agents Chemother; 2016 May; 60(5):3065-9. PubMed ID: 26953201 [TBL] [Abstract][Full Text] [Related]
11. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo. Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564 [TBL] [Abstract][Full Text] [Related]